Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review.
CONCLUSION: There is not yet enough evidence to support the regular use of lopinavir/ritonavir in the treatment of COVID19. Further clinical trials are needed to evaluate lopinavir/ritonavir's efficacy in treatment.
PMID: 33121422 [PubMed - as supplied by publisher]
Source: Infectious Disorders Drug Targets - Category: Infectious Diseases Authors: Hariyanto TI, Kristine E, Jillian Hardi C, Kurniawan A Tags: Infect Disord Drug Targets Source Type: research
More News: Clinical Trials | Coronavirus | COVID-19 | Gastroenterology | Infectious Diseases | Kaletra | Norvir | SARS | Study